Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum 9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.

Bullboard (GREY:DGCRF)

View:
Post by so_wrongon Jun 13, 2016 12:00pm

What now?

Excuse my ignorance, but does anyone know what we should be expecting going forward? My trading account still shows that I have shares in cur, but since it is now de-listed I obviously can't sell ...more  
Comment by Dibah42on Apr 24, 2016 3:16pm

RE:While yur still bent over....

I don't evaluate an early stage biotech on the banal metrics of last year's revenues, ebidat, loss, etc.. but for what it has in the pipeline and what it might bring to the market in the near ...more  
Post by somweyungguyon Apr 23, 2016 4:07pm

While yur still bent over....

Dibbah would like you to push the pump on this PLI company with a 2 BILLION, yeah 2 BILLION market cap and 24M in revenue with a 56 M loss last year... Yeah...load up ; - )
Post by Dibah42on Apr 23, 2016 4:01pm

Adieu or au revoir

I would like to thank all you gentlemen (and ladies) for your contribution to this bb.  It has been a long decade-plus of interest and activity in this company.  Alas it ended up not the way ...more  
Comment by oceanblvdon Apr 19, 2016 11:18am

RE:RE:what will we receive?

less than .01 any sale at a penny or better in my view is right
Post by pierrot888on Apr 17, 2016 9:08am

on ferme les livres

JEAN-MICHEL POIRIER Le Soleil   (Qubec) La socit de Qubec spcialise dans la conception de tests pour diagnostiquer le cancer, DiagnoCure (TSX : CUR) ferme les livres. L' ...more  
Post by clangordonon Apr 15, 2016 5:31pm

what will we receive?

any informed views? thank you
Post by oceanblvdon Mar 22, 2016 11:33am

whats left?

if history is correct there will end up being zero left. the best this company could do was .12 cents on its only asset. 
Post by Dibah42on Mar 08, 2016 3:11pm

Due Bill Period

So what do you think we'll be trading at once this "doobill-schmoobill" is out of the way next week? And which market will CUR be traded on?  Here's a list of assets:  1 ...more  
Post by Dibah42on Mar 01, 2016 7:34pm

hmmm..

Now this is getting interesting.  Up 17.25% with a vol of 275k with no news????! Anyone has a hunch?  Deal announcement coming for GCC/PCP?
Comment by oceanblvdon Feb 24, 2016 10:04am

RE:RE:SHAREHOLDERS WHO VOTES (YES) MUST NOT COMPLAIN

what does that mean ? PCA3 was a gold mine we just had incompetant miners .
Comment by bingostaron Feb 24, 2016 9:17am

RE:SHAREHOLDERS WHO VOTES (YES) MUST NOT COMPLAIN

Aeterna Zentaris Commences Promotional Activities for APIFINY Prostate Cancer Blood Test . Business Wire Aeterna Zentaris Inc. February 23, Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the Company) ...more  
Comment by bingostaron Feb 18, 2016 2:31pm

RE:RE:RE:RE:valuation

You are only acrual accountant.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities